Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)

ClinicalTrials.gov ID: NCT02709746

Public ClinicalTrials.gov record NCT02709746. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 7, 2026, 9:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Interventional, Randomised, Double-blind, Placebo-controlled, Active Reference (Fluoxetine), Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years, With Major Depressive Disorder (MDD)

Study identification

NCT ID
NCT02709746
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
H. Lundbeck A/S
Industry
Enrollment
784 participants

Conditions and interventions

Interventions

  • Fluoxetine 20 mg/day Drug
  • Placebo Other
  • Vortioxetine 10 mg/day Drug
  • Vortioxetine 20 mg/day Drug

Drug · Other

Eligibility (public fields only)

Age range
12 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2016
Primary completion
Jul 1, 2019
Completion
Jul 29, 2019
Last update posted
Aug 18, 2020

2016 – 2019

United States locations

U.S. sites
42
U.S. states
20
U.S. cities
40
Facility City State ZIP Site status
US1369 Dothan Alabama
US1333 Tucson Arizona
US1310 Little Rock Arkansas
US1062 Costa Mesa California
US1387 Downey California
US1114 Escondido California
US1118 Glendale California
US1123 Imperial California
US1160 Renew Behavioral Health, Inc. Long Beach California
US1368 Orange California
US1370 Panorama City California
US1351 Wildomar California
US1133 Washington D.C. District of Columbia
US1217 Gainesville Florida
US1229 Orange City Florida
US1009 Atlanta Georgia
US1313 Marietta Georgia
US1311 Naperville Illinois
US1315 Naperville Illinois
US1103 Oak Brook Illinois
US1386 Wichita Kansas
US1261 Lake Charles Louisiana
US1015 Baltimore Maryland
US1385 Ericksen Research And Development Clinton Mississippi
US1064 Creve Coeur Missouri
US1314 O'Fallon Missouri
US1266 Saint Charles Missouri
US1312 Berlin New Jersey
US1222 Princeton New Jersey
US1317 New York New York
US1171 Rochester New York
US1190 Staten Island New York
US1051 Cincinnati Ohio
US1054 Cleveland Ohio
US1334 Middleburg Heights Ohio
US1323 Oklahoma City Oklahoma
US1329 Oklahoma City Oklahoma
US1328 Austin Texas
US1320 Plano Texas
US1162 San Antonio Texas
US1308 Orem Utah
US1309 Richmond Virginia

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 82 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02709746, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 18, 2020 · Synced May 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02709746 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →